Imperial College London

Professor Karen Polizzi

Faculty of EngineeringDepartment of Chemical Engineering

Professor of Biotechnology
 
 
 
//

Contact

 

+44 (0)20 7594 2851k.polizzi

 
 
//

Location

 

411ACE ExtensionSouth Kensington Campus

//

Summary

 

Summary

The main theme of my laboratory is to detect and correct "bad behaviour" in cells using a combination of in vivo biosensors and synthetic biology

*Not a scientist?  See below for the Plain English version of this webpage.*

What are in vivo biosensors?  Most classical biosensors (like those used in blood sugar monitoring) rely on electrochemistry to convert the concentration of a molecule of interest into a digital display.  However, there are a whole class of biosensors that are entirely genetically-encoded either by fusing a transcriptional element that detects the molecule of interest to a reporter protein like GFP or through proteins that have the ability to sense the molecule and convert the concentration into an output.  These genetically-encoded sensors are convenient tools for monitoring what is going on inside living cells since they don't require the addition of exogenous reagents or abiotic elements.  We use sensors like these to monitor cellular behaviour under different conditions.  They can be used in conjunction with external stimuli (e.g. changing medium cells are fed) to control cellular behaviour.

What is synthetic biology?  Synthetic biology is an engineering approach to biology which attempts biological redesign from a set of standard, well-characterised "parts" (genetic elements like promoter sequences and ribosome binding sites).  Synthetic biology is a powerful tool to exploit the vast biological knowledge that has been accumulating since the advent of recombinant DNA technology.  We use synthetic biology to design new circuits to control cellular behaviour.  These circuits can be linked to the biosensor output from above in order to create a self-correction system within an organism of interest.

 Research Themes

  • Biopharmaceutical processing
  • Neurodegeneration and ageing
  • Tools for synthetic biology

Plain English version:

Since the 1970's, scientists have had the ability to change the genes of an organism-- in fact, we've gotten pretty good at doing so!  This allows us to make organisms do work for our benefit- from making medications to manufacturing materials for us. 

Work in my laboratory has two goals.  First, we try to develop proteins that can give us a window to what is going onside in an organism by turning colours to warn us when things have gone wrong inside the cell.  Second, based on that coloured signal, we try to add genes to the organism that help us correct the problem.  Our ultimate goal is to develop self-correcting organisms.

Publications

Journals

Kotidis P, Marbiah M, Donini R, et al., 2022, Rapid Antibody Glycoengineering in CHO Cells Via RNA Interference and CGE-LIF N-Glycomics., Methods Mol Biol, Vol:2370, Pages:147-167

Lange OJ, Polizzi KM, 2021, Click it or stick it: Covalent and non-covalent methods for protein-self assembly, Current Opinion in Systems Biology, Vol:28, ISSN:2452-3100, Pages:100374-100374

Aw R, Ashik MR, Islam AAZM, et al., 2021, Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine., Vaccine

Stefani I, Blaudin de The F-X, Kontoravdi K, et al., 2021, Model identifies genetic predisposition of Alzheimer’s disease as key decider in cell susceptibility to stress, International Journal of Molecular Sciences, Vol:22, ISSN:1422-0067, Pages:1-15

Chee SM, Polizzi K, Freemont P, et al., 2021, A GenoChemetic strategy for derivatization of the violacein natural product scaffold, Acs Chemical Biology, ISSN:1554-8929

More Publications